Péricart, Sarah
Waysse, Charlotte
Siegfried, Aurore
Struski, Stephanie
Delabesse, Eric
Laurent, Camille
Evrard, Solène
Article History
Received: 12 June 2019
Revised: 7 October 2019
Accepted: 14 October 2019
First Online: 5 December 2019
Compliance with ethical standards
: <b>Ethics approval and consent to participate</b> Tissue samples were collected at the CRB biobank (DC-2008-463 and transfer agreement AC-2008-820) and processed following standard ethical procedures (Helsinki Declaration of 1975) after obtaining written informed consent from the patient. The study was approved by the local ethical committee (Comité de Protection des Personnes Sud-Ouest et Outremer II). For cytogenetics analysis, fresh and thawed samples from the patient were obtained after informed consent and stored at the HIMIP (INSERM-Midi Pyrénées Malignant Blood Diseases collection). According to the French law, the HIMIP collection was declared to the Ministry of Higher Education and Research (DC 2008-307 collection 1) for which a transfer agreement (AC 2008-129) was obtained after approbation by the ethical committee (CPP). Clinical and biological annotations of the samples were declared to the CNIL (Comité National Informatique et Libertés ie Data processing and Liberties National Committee).
: The authors declare that they have no conflict of interest.
: The opinions, results, and conclusions reported in this paper are those of the authors and are independent of the funding sources. No endorsement by Institute Universitaire de Cancer de Toulouse is intended or should be inferred. Parts of this material are based on data and/or information compiled and provided by the Institute Universitaire de Cancer de Toulouse. However, the analyses, conclusions, opinions, and statements expressed in the material are those of the author(s), and not necessarily those of Institute Universitaire de Cancer de Toulouse.